Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Preferred Equity

Arbutus Biopharma Cp Preferred Equity Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Preferred Equity from 2017 to 2018.
  • Arbutus Biopharma Cp Preferred Equity for the quarter ending September 09, 2018 was $123m a 59.69% increase of 74m year over year
  • Arbutus Biopharma Cp Preferred Equity for the last 12 months ending September 09, 2018 was $123m a 59.69% increase of 74m year over year
Other Balance Sheet Metrics:
  • Arbutus Biopharma Cp Total Assets for the quarter ending December 12, 2018 was $228m a -18.48% decrease of -42m year over year
  • Arbutus Biopharma Cp Other Liabilities for the quarter ending December 12, 2018 was $17m a -61.02% decrease of -10m year over year
  • Arbutus Biopharma Cp Total Equity for the quarter ending December 12, 2018 was $200m a -16.09% decrease of -32m year over year
View Chart On Koyfin

Quarterly ABUS Preferred Equity Data

09/2018$123m
06/2018$121m
03/2018$118m
12/2017$50m

Annual ABUS Preferred Equity Data

2017$50m